Novartis Investigative Site

Goes 4462 RA

0 studies enrolling now · 5 studies all time

What they study most

Atherosclerotic Cardiovascular Disease, Breast Cancer, Cardiovascular Disease, Chronic Heart Failure, Familial Hypercholesterolemia, Heart Failure With Reduced Ejection Fraction, Symptomatic Atherosclerosis, Type 2 Diabetes Mellitus, Type2 Diabetes

Studies at this site

• Study to Assess the Safety and Efficacy of Ribociclib (LEE011) in Combination With Letrozole for the Treatment of Men and Pre/Postmenopausal Women With HR+ HER2- aBC — Completed
• An Extension Trial of Inclisiran in Participants With Cardiovascular Disease and High Cholesterol — Completed
• This Study Will Evaluate the Efficacy and Safety of LCZ696 Compared to Enalapril on Morbidity and Mortality of Patients With Chronic Heart Failure — Stopped early
• LCZ696 Compared to Valsartan in Patients With Chronic Heart Failure and Preserved Left-ventricular Ejection Fraction — Completed
• Aliskiren Trial in Type 2 Diabetes Using Cardiovascular and Renal Disease Endpoints (Core and Extension Phases) — Stopped early